←back to thread

275 points swores | 1 comments | | HN request time: 0.29s | source
Show context
MisterDizzy ◴[] No.40173334[source]
Drug companies are unambiguously out of control. Some of these new molecules don't even need to be invented, they're just legally distinct repackaging of something they can't gouge on anymore. These companies could, if they had an incentive to do so, research effective off-label uses of existing drugs, say. But there's no money in that. There is a ton of money in making legally distinct "new" drugs that do the same thing as newly-generic drugs. It's unacceptable what they get away with.

Covid ought to have been the final straw that brought all sides together to do something about drug companies.

replies(5): >>40173477 #>>40173731 #>>40173886 #>>40173915 #>>40173958 #
acchow ◴[] No.40173731[source]
What’s stopping people from using the old packaging when the patent expires?
replies(3): >>40173806 #>>40173811 #>>40173913 #
1. sowbug ◴[] No.40173913[source]
"People" are the same drug companies that would rather use their manufacturing capabilities for high-margin on-patent drugs.

For a particularly sad example, certain kinds of testicular cancer are considered curable with off-patent drugs like cisplatin and etoposide. But those drugs are often unavailable simply because nobody wants to manufacture such low-margin drugs. See, for example,https://www.fiercepharma.com/pharma/oncology-drug-shortage-c....